- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
Bayer self-reported a global-issued Levitra symposium invitation sent to UK delegates without UK certification. It lacked required prescribing/AE info, used an unapproved…
Anonymous complaint said a Xarelto GP ad calling dosing “simple” downplayed anticoagulant risks. PMCPA ruled “simple” referred only to once-daily dosing and…
MSD challenged a Victoza detail aid using a “triple composite endpoint” shown in prominent red boxes. PMCPA ruled the presentation misleading (Clause…
Anonymous NHS HCPs complained about excessive hospitality at an ISU meeting in Belfast. Allergan funded venue/AV via an educational grant. Panel found…
Roche-sponsored AAV workshop was deemed promotional due to slides and signposting to rituximab content, and it implied Mabthera use across all AAV…
Ex-employee alleged excessive sponsorship of 33 UK HCPs to FIGO Rome 2012. Panel reviewed costs (travel, hotel, dinners) under Clause 19.1 and…
A Sanofi representative persuaded an NHS administrator to email a promotional GLP-1 webcast invite to GP practices via NHS.net, without opt-in permission…
Allergan was ruled in breach after a meeting presentation and representative conduct implied Vistabel/Botox was more potent than Bocouture/Xeomin, contrary to SPC…
Lilly lung cancer maintenance ad appeared on a US creative media site without a password after an agency award submission. Panel found…
Alexion’s entry in a UK society meeting programme was alleged to promote an unlicensed medicine. Panel noted potentially ambiguous “late-stage therapies” wording…
Astellas UK admitted multiple promotional items referenced two medicines but included prescribing information for only one. The Panel ruled breaches of Clauses…
A GP alleged inappropriate closeness between a representative and a GP partner, access issues, and possible funding of a practice barbecue. The…
ViiV admitted a February 2015 journal issue carried a 2-page Triumeq ad plus a belly band wrap, exceeding the Code’s 2-page limit…
AstraZeneca challenged Chiesi’s Fostair leavepiece headline “for an extra fine day”. PMCPA ruled it ambiguous, misleading and unsubstantiated (Clauses 7.2, 7.4). Wider…
A rheumatologist complained about a Pfizer rep’s conduct, including an alleged ITU patient on a competitor drug. On appeal, the patient was…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.